Charles River Laboratories International Inc [CRL] stock prices are up 2.65% to $198.15 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CRL shares have gain 5.89% over the last week, with a monthly amount glided 17.10%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on December 15, 2025, when BofA Securities upgraded its rating to a Buy but kept the price target unchanged to $225 for it. Previously, Argus upgraded its rating to Buy on November 17, 2025. On November 06, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $199 on the stock. William Blair upgraded its rating to an Outperform. Barclays upgraded its rating to an Overweight but $195 remained the price target by the analyst firm on October 02, 2025. Jefferies upgraded its rating to Buy for this stock on September 09, 2025, but kept the price target unchanged to $195. In a note dated July 09, 2025, Citigroup upgraded a Buy rating on this stock but restated the target price of $200.
The stock price of Charles River Laboratories International Inc [CRL] has been fluctuating between $91.86 and $199.66 over the past year. Currently, Wall Street analysts expect the stock to reach $194.83 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $198.15 at the most recent close of the market. An investor can expect a potential drop of -1.68% based on the average CRL price forecast.
Analyzing the CRL fundamentals
The Charles River Laboratories International Inc [NYSE:CRL] reported sales of 4.02B for trailing twelve months, representing a drop of -0.49%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 195.31 points at the first support level, and at 192.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 200.79, and for the 2nd resistance point, it is at 203.42.
Ratios To Look Out For
It’s worth pointing out that Charles River Laboratories International Inc [NYSE:CRL]’s Current Ratio is 1.37. In addition, the Quick Ratio stands at 1.10 and the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 2.42, the price to book ratio is 2.86.
Transactions by insiders
Recent insider trading involved Joseph LaPlume, Officer, that happened on Aug 22 ’25 when 400.0 shares were purchased. EVP, Corp Strategy & Develop, LaPlume Joseph W completed a deal on Aug 18 ’25 to sell 800.0 shares. Meanwhile, Former Director WALLMAN RICHARD F bought 22500.0 shares on Aug 18 ’25.
